WTP, Yes, we can drop the word strategy. The plan to have a US presence, operation, trials and possible NASDAQ listing do seem to have been put on the back burner. This is different from and separate from financing from firms who happen to be based in the US.
Moving on, I think the appointment is a clear indication of the direction of travel for Scancell. They will pursue licencing deals for all of their platforms. This has been the suggestion by Trinity Delta for a couple of years in their SP predictions.
Ray, I’m not sure what benefits treatments would bring if you have already sustained damage, for example to the heart. Hopefully a vaccine will prevent the disease taking hold and being able to cause damage in the first place. Another reason why a long term, effective vaccine is so important. The virus cannot be control by distancing measures however stringent.
Crackin, Forgot to say, you are right Boris has lost the plot, I doubt he ever had the plot ANYTHING positive on Covidity will send this over 20p - those were the days my friend I thought they’d never end.
Max, You are correct as CH said: Great science leads to great products Great products lead to great data Great data leads to great deals
We will only get the great data once trials start, so hopefully soon and a news release accordingly. Until we hear something concrete, I’m afraid the SP will fluctuate according to the whim of buyers and sellers. Since CH uttered those words we do have another string to the bow in Covidity.